+1,031.9%
NBIS vs THC
+62.6%
+969.4%
-58.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +7.5% | +0.6% | +6.9% | +7.4% |
| 7D | +8.2% | -0.7% | +8.9% | +8.3% |
| 30D | +3.4% | +1.3% | +2.1% | +3.2% |
| 3M | -12.8% | +64.2% | -77.1% | -24.1% |
| 6M | +131.5% | +8.3% | +123.3% | +131.3% |
| YTD | +170.5% | +33.4% | +137.1% | +148.9% |
| 1Y | +248.8% | +37.7% | +211.1% | +217.4% |
| All | +1,031.9% | +62.6% | +969.4% | +783.2% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling